Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

E-cadherin and Fibronectin Expressions Have No Prognostic Role in Stage II Ductal Breast Cancer

GRZEGORZ SWIATONIOWSKI, RAFAL MATKOWSKI, ELZBIETA SUDER, SZYMON BRUZEWICZ, MONIKA SETTA, JAN KORNAFEL, ANDRZEJ POLOZOWSKI and PAWEL SUROWIAK
Anticancer Research July 2005, 25 (4) 2879-2883;
GRZEGORZ SWIATONIOWSKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RAFAL MATKOWSKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ELZBIETA SUDER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SZYMON BRUZEWICZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: szybru@hyg.am.wroc.pl
MONIKA SETTA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JAN KORNAFEL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANDRZEJ POLOZOWSKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PAWEL SUROWIAK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: The aim of the study was to describe the expressions of E-cadherin (EC) and fibronectin (FN) and their prognostic value in radically-treated ductal breast cancer. Patients and Methods: Ninety-eight patients, aged 26-86 (median, 57) with stage II G2 or G3 tumors, were subjected to a retrospective analysis. Results: No significant associations were observed between the levels of the proteins studied and patient or cancer features, with the exception of relationships between FN expression and the histological grade of the tumor or hormonal status of the subjects. None of the markers showed a correlation with survival in multivariate analysis. Consequently, the experiment revealed no prognostic value of EC or FN expression in a homogenous patient group with stage II G2 or G3 ductal breast carcinoma. Conclusion: Further studies, on other uniform populations, with tumor features different from those described here, are necessary in order to reveal the prognostic significance of the molecules discussed.

  • Breast cancer
  • ductal breast cancer
  • E-cadherin
  • fibronectin
  • prognosis

Footnotes

  • Received February 16, 2005.
  • Accepted May 5, 2005.
  • Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research: 25 (4)
Anticancer Research
Vol. 25, Issue 4
1 Jul 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
E-cadherin and Fibronectin Expressions Have No Prognostic Role in Stage II Ductal Breast Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
11 + 9 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
E-cadherin and Fibronectin Expressions Have No Prognostic Role in Stage II Ductal Breast Cancer
GRZEGORZ SWIATONIOWSKI, RAFAL MATKOWSKI, ELZBIETA SUDER, SZYMON BRUZEWICZ, MONIKA SETTA, JAN KORNAFEL, ANDRZEJ POLOZOWSKI, PAWEL SUROWIAK
Anticancer Research Jul 2005, 25 (4) 2879-2883;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
E-cadherin and Fibronectin Expressions Have No Prognostic Role in Stage II Ductal Breast Cancer
GRZEGORZ SWIATONIOWSKI, RAFAL MATKOWSKI, ELZBIETA SUDER, SZYMON BRUZEWICZ, MONIKA SETTA, JAN KORNAFEL, ANDRZEJ POLOZOWSKI, PAWEL SUROWIAK
Anticancer Research Jul 2005, 25 (4) 2879-2883;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Magnolol Suppresses Osteosarcoma Progression via Apoptosis Induction and EGFR/AKT Pathway Inactivation in a U-2 OS Xenograft Model
  • The Combination of the Autophagy Inhibitor Chloroquine and Recombinant Methioninase Has Selective Synergistic Efficacy on Human Colon Cancer Cells But Not on Normal Human Fibroblasts
  • Amentoflavone Enhances the Anti-tumor Activity of Regorafenib by Promoting Apoptosis and Inhibiting NF-κB–mediated Metastasis in Hepatocellular Carcinoma
Show more Experimental Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire